AI assistant
Sending…
INTUITIVE SURGICAL INC — Director's Dealing 2024
Nov 27, 2024
29809_dirs_2024-11-26_3d9b376d-f192-4c8f-97f8-396c3cbe9f7f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INTUITIVE SURGICAL INC (ISRG)
CIK: 0001035267
Period of Report: 2024-11-26
Reporting Person: Samath Jamie (CFO and Head of Business Techn)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-11-26 | Common Stock | M | 54 | $347.4167 | Acquired | 8811 | Direct |
| 2024-11-26 | Common Stock | S | 54 | $542.06 | Disposed | 8757 | Direct |
| 2024-11-26 | Common Stock | M | 54 | $245.6 | Acquired | 8811 | Direct |
| 2024-11-26 | Common Stock | S | 54 | $542.06 | Disposed | 8757 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-11-26 | Non-Qualified Stock Option (right to buy) | $245.6 | M | 54 | Disposed | 2031-02-26 | Common Stock (54) | Direct |
| 2024-11-26 | Non-Qualified Stock Option (right to buy) | $347.4167 | M | 54 | Disposed | 2031-08-26 | Common Stock (54) | Direct |
Footnotes
F1: The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on May 6, 2025.
F2: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F3: Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
More from INTUITIVE SURGICAL INC
Regulatory Filings
2026
May 21
Interim / Quarterly Report
2026
Apr 22
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 2